COVID-19 Impact on Global Haemophilus Influenzae Type B Vaccine Market Insights, Forecast to 2026
Haemophilus Influenzae Type B Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Haemophilus Influenzae Type B Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Haemophilus Influenzae Type B Vaccine market is segmented into
The Haemophilus Influenzae Type B Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Haemophilus Influenzae Type B Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Haemophilus Influenzae Type B Vaccine Market Share Analysis
Haemophilus Influenzae Type B Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Haemophilus Influenzae Type B Vaccine business, the date to enter into the Haemophilus Influenzae Type B Vaccine market, Haemophilus Influenzae Type B Vaccine product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Haemophilus Influenzae Type B Vaccine market is segmented into
- Liquid Monovalent HIB
- Liquid Combination HIB
- Lyophilized Monovalent HIB
- Lyophilized Combination HIB
- Hospital
- Research Institutions
- Pharmaceutical and Biotechnology Companies
- Academic Institutions
- Other
The Haemophilus Influenzae Type B Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Haemophilus Influenzae Type B Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Haemophilus Influenzae Type B Vaccine Market Share Analysis
Haemophilus Influenzae Type B Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Haemophilus Influenzae Type B Vaccine business, the date to enter into the Haemophilus Influenzae Type B Vaccine market, Haemophilus Influenzae Type B Vaccine product introduction, recent developments, etc.
The major vendors covered:
- Novartis
- Merck
- Sanofi
- GlaxoSmithKline
- Takeda Pharmaceuticals Company
- Walvax Biotechnology
- Lanzhou Institute of Biologica
- Immunize BC
1 STUDY COVERAGE
1.1 Haemophilus Influenzae Type B Vaccine Product Introduction
1.2 Market Segments
1.3 Key Haemophilus Influenzae Type B Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Type
1.4.2 Liquid Monovalent HIB
1.4.3 Liquid Combination HIB
1.4.4 Lyophilized Monovalent HIB
1.4.5 Lyophilized Combination HIB
1.5 Market by Application
1.5.1 Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Research Institutions
1.5.4 Pharmaceutical and Biotechnology Companies
1.5.5 Academic Institutions
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Haemophilus Influenzae Type B Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Haemophilus Influenzae Type B Vaccine Industry
1.6.1.1 Haemophilus Influenzae Type B Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Haemophilus Influenzae Type B Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Haemophilus Influenzae Type B Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Haemophilus Influenzae Type B Vaccine Market Size Estimates and Forecasts
2.1.1 Global Haemophilus Influenzae Type B Vaccine Revenue 2015-2026
2.1.2 Global Haemophilus Influenzae Type B Vaccine Sales 2015-2026
2.2 Haemophilus Influenzae Type B Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Haemophilus Influenzae Type B Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Haemophilus Influenzae Type B Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL HAEMOPHILUS INFLUENZAE TYPE B VACCINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Haemophilus Influenzae Type B Vaccine Sales by Manufacturers
3.1.1 Haemophilus Influenzae Type B Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Haemophilus Influenzae Type B Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers
3.2.1 Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Haemophilus Influenzae Type B Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Haemophilus Influenzae Type B Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Haemophilus Influenzae Type B Vaccine Revenue in 2019
3.2.5 Global Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Haemophilus Influenzae Type B Vaccine Price by Manufacturers
3.4 Haemophilus Influenzae Type B Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Haemophilus Influenzae Type B Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Haemophilus Influenzae Type B Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Haemophilus Influenzae Type B Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Haemophilus Influenzae Type B Vaccine Market Size by Type (2015-2020)
4.1.1 Global Haemophilus Influenzae Type B Vaccine Sales by Type (2015-2020)
4.1.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2015-2020)
4.1.3 Haemophilus Influenzae Type B Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Haemophilus Influenzae Type B Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Haemophilus Influenzae Type B Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Haemophilus Influenzae Type B Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Haemophilus Influenzae Type B Vaccine Market Size by Application (2015-2020)
5.1.1 Global Haemophilus Influenzae Type B Vaccine Sales by Application (2015-2020)
5.1.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2015-2020)
5.1.3 Haemophilus Influenzae Type B Vaccine Price by Application (2015-2020)
5.2 Haemophilus Influenzae Type B Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Haemophilus Influenzae Type B Vaccine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Haemophilus Influenzae Type B Vaccine by Country
6.1.1 North America Haemophilus Influenzae Type B Vaccine Sales by Country
6.1.2 North America Haemophilus Influenzae Type B Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Type
6.3 North America Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Haemophilus Influenzae Type B Vaccine by Country
7.1.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Country
7.1.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Type
7.3 Europe Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Haemophilus Influenzae Type B Vaccine by Region
8.1.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region
8.1.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Haemophilus Influenzae Type B Vaccine by Country
9.1.1 Latin America Haemophilus Influenzae Type B Vaccine Sales by Country
9.1.2 Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Type
9.3 Central & South America Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine by Country
10.1.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country
10.1.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Haemophilus Influenzae Type B Vaccine Products Offered
11.1.5 Novartis Recent Development
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description, Business Overview and Total Revenue
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Haemophilus Influenzae Type B Vaccine Products Offered
11.2.5 Merck Recent Development
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description, Business Overview and Total Revenue
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Haemophilus Influenzae Type B Vaccine Products Offered
11.3.5 Sanofi Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Products Offered
11.4.5 GlaxoSmithKline Recent Development
11.5 Takeda Pharmaceuticals Company
11.5.1 Takeda Pharmaceuticals Company Corporation Information
11.5.2 Takeda Pharmaceuticals Company Description, Business Overview and Total Revenue
11.5.3 Takeda Pharmaceuticals Company Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Products Offered
11.5.5 Takeda Pharmaceuticals Company Recent Development
11.6 Walvax Biotechnology
11.6.1 Walvax Biotechnology Corporation Information
11.6.2 Walvax Biotechnology Description, Business Overview and Total Revenue
11.6.3 Walvax Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Products Offered
11.6.5 Walvax Biotechnology Recent Development
11.7 Lanzhou Institute of Biologica
11.7.1 Lanzhou Institute of Biologica Corporation Information
11.7.2 Lanzhou Institute of Biologica Description, Business Overview and Total Revenue
11.7.3 Lanzhou Institute of Biologica Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Products Offered
11.7.5 Lanzhou Institute of Biologica Recent Development
11.8 Immunize BC
11.8.1 Immunize BC Corporation Information
11.8.2 Immunize BC Description, Business Overview and Total Revenue
11.8.3 Immunize BC Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Immunize BC Haemophilus Influenzae Type B Vaccine Products Offered
11.8.5 Immunize BC Recent Development
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Haemophilus Influenzae Type B Vaccine Products Offered
11.1.5 Novartis Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Haemophilus Influenzae Type B Vaccine Market Estimates and Projections by Region
12.1.1 Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Haemophilus Influenzae Type B Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Haemophilus Influenzae Type B Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Haemophilus Influenzae Type B Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Haemophilus Influenzae Type B Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Haemophilus Influenzae Type B Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Haemophilus Influenzae Type B Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Haemophilus Influenzae Type B Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Haemophilus Influenzae Type B Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Haemophilus Influenzae Type B Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Haemophilus Influenzae Type B Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Haemophilus Influenzae Type B Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Haemophilus Influenzae Type B Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Haemophilus Influenzae Type B Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Haemophilus Influenzae Type B Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Haemophilus Influenzae Type B Vaccine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Haemophilus Influenzae Type B Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Haemophilus Influenzae Type B Vaccine Product Introduction
1.2 Market Segments
1.3 Key Haemophilus Influenzae Type B Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Type
1.4.2 Liquid Monovalent HIB
1.4.3 Liquid Combination HIB
1.4.4 Lyophilized Monovalent HIB
1.4.5 Lyophilized Combination HIB
1.5 Market by Application
1.5.1 Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Research Institutions
1.5.4 Pharmaceutical and Biotechnology Companies
1.5.5 Academic Institutions
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Haemophilus Influenzae Type B Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Haemophilus Influenzae Type B Vaccine Industry
1.6.1.1 Haemophilus Influenzae Type B Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Haemophilus Influenzae Type B Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Haemophilus Influenzae Type B Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Haemophilus Influenzae Type B Vaccine Market Size Estimates and Forecasts
2.1.1 Global Haemophilus Influenzae Type B Vaccine Revenue 2015-2026
2.1.2 Global Haemophilus Influenzae Type B Vaccine Sales 2015-2026
2.2 Haemophilus Influenzae Type B Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Haemophilus Influenzae Type B Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Haemophilus Influenzae Type B Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL HAEMOPHILUS INFLUENZAE TYPE B VACCINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Haemophilus Influenzae Type B Vaccine Sales by Manufacturers
3.1.1 Haemophilus Influenzae Type B Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Haemophilus Influenzae Type B Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers
3.2.1 Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Haemophilus Influenzae Type B Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Haemophilus Influenzae Type B Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Haemophilus Influenzae Type B Vaccine Revenue in 2019
3.2.5 Global Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Haemophilus Influenzae Type B Vaccine Price by Manufacturers
3.4 Haemophilus Influenzae Type B Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Haemophilus Influenzae Type B Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Haemophilus Influenzae Type B Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Haemophilus Influenzae Type B Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Haemophilus Influenzae Type B Vaccine Market Size by Type (2015-2020)
4.1.1 Global Haemophilus Influenzae Type B Vaccine Sales by Type (2015-2020)
4.1.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2015-2020)
4.1.3 Haemophilus Influenzae Type B Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Haemophilus Influenzae Type B Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Haemophilus Influenzae Type B Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Haemophilus Influenzae Type B Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Haemophilus Influenzae Type B Vaccine Market Size by Application (2015-2020)
5.1.1 Global Haemophilus Influenzae Type B Vaccine Sales by Application (2015-2020)
5.1.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2015-2020)
5.1.3 Haemophilus Influenzae Type B Vaccine Price by Application (2015-2020)
5.2 Haemophilus Influenzae Type B Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Haemophilus Influenzae Type B Vaccine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Haemophilus Influenzae Type B Vaccine by Country
6.1.1 North America Haemophilus Influenzae Type B Vaccine Sales by Country
6.1.2 North America Haemophilus Influenzae Type B Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Type
6.3 North America Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Haemophilus Influenzae Type B Vaccine by Country
7.1.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Country
7.1.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Type
7.3 Europe Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Haemophilus Influenzae Type B Vaccine by Region
8.1.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region
8.1.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Haemophilus Influenzae Type B Vaccine by Country
9.1.1 Latin America Haemophilus Influenzae Type B Vaccine Sales by Country
9.1.2 Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Type
9.3 Central & South America Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine by Country
10.1.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country
10.1.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Haemophilus Influenzae Type B Vaccine Products Offered
11.1.5 Novartis Recent Development
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description, Business Overview and Total Revenue
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Haemophilus Influenzae Type B Vaccine Products Offered
11.2.5 Merck Recent Development
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description, Business Overview and Total Revenue
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Haemophilus Influenzae Type B Vaccine Products Offered
11.3.5 Sanofi Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Products Offered
11.4.5 GlaxoSmithKline Recent Development
11.5 Takeda Pharmaceuticals Company
11.5.1 Takeda Pharmaceuticals Company Corporation Information
11.5.2 Takeda Pharmaceuticals Company Description, Business Overview and Total Revenue
11.5.3 Takeda Pharmaceuticals Company Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Products Offered
11.5.5 Takeda Pharmaceuticals Company Recent Development
11.6 Walvax Biotechnology
11.6.1 Walvax Biotechnology Corporation Information
11.6.2 Walvax Biotechnology Description, Business Overview and Total Revenue
11.6.3 Walvax Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Products Offered
11.6.5 Walvax Biotechnology Recent Development
11.7 Lanzhou Institute of Biologica
11.7.1 Lanzhou Institute of Biologica Corporation Information
11.7.2 Lanzhou Institute of Biologica Description, Business Overview and Total Revenue
11.7.3 Lanzhou Institute of Biologica Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Products Offered
11.7.5 Lanzhou Institute of Biologica Recent Development
11.8 Immunize BC
11.8.1 Immunize BC Corporation Information
11.8.2 Immunize BC Description, Business Overview and Total Revenue
11.8.3 Immunize BC Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Immunize BC Haemophilus Influenzae Type B Vaccine Products Offered
11.8.5 Immunize BC Recent Development
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Haemophilus Influenzae Type B Vaccine Products Offered
11.1.5 Novartis Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Haemophilus Influenzae Type B Vaccine Market Estimates and Projections by Region
12.1.1 Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Haemophilus Influenzae Type B Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Haemophilus Influenzae Type B Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Haemophilus Influenzae Type B Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Haemophilus Influenzae Type B Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Haemophilus Influenzae Type B Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Haemophilus Influenzae Type B Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Haemophilus Influenzae Type B Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Haemophilus Influenzae Type B Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Haemophilus Influenzae Type B Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Haemophilus Influenzae Type B Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Haemophilus Influenzae Type B Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Haemophilus Influenzae Type B Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Haemophilus Influenzae Type B Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Haemophilus Influenzae Type B Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Haemophilus Influenzae Type B Vaccine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Haemophilus Influenzae Type B Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Haemophilus Influenzae Type B Vaccine Market Segments
Table 2. Ranking of Global Top Haemophilus Influenzae Type B Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Type 2020-2026 (M Doses) & (US$ Million)
Table 4. Major Manufacturers of Liquid Monovalent HIB
Table 5. Major Manufacturers of Liquid Combination HIB
Table 6. Major Manufacturers of Lyophilized Monovalent HIB
Table 7. Major Manufacturers of Lyophilized Combination HIB
Table 8. COVID-19 Impact Global Market: (Four Haemophilus Influenzae Type B Vaccine Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Haemophilus Influenzae Type B Vaccine Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Haemophilus Influenzae Type B Vaccine Players to Combat Covid-19 Impact
Table 13. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Application 2020-2026 (M Doses)
Table 14. Global Haemophilus Influenzae Type B Vaccine Market Size by Region (M Doses) & (US$ Million): 2020 VS 2026
Table 15. Global Haemophilus Influenzae Type B Vaccine Sales by Regions 2015-2020 (M Doses)
Table 16. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Regions (2015-2020)
Table 17. Global Haemophilus Influenzae Type B Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturers (2015-2020) (M Doses)
Table 19. Global Haemophilus Influenzae Type B Vaccine Sales Share by Manufacturers (2015-2020)
Table 20. Global Haemophilus Influenzae Type B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Haemophilus Influenzae Type B Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Haemophilus Influenzae Type B Vaccine as of 2019)
Table 22. Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Haemophilus Influenzae Type B Vaccine Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Haemophilus Influenzae Type B Vaccine Price (2015-2020) (USD/Dose)
Table 25. Haemophilus Influenzae Type B Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Haemophilus Influenzae Type B Vaccine Product Type
Table 27. Date of International Manufacturers Enter into Haemophilus Influenzae Type B Vaccine Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2015-2020) (M Doses)
Table 30. Global Haemophilus Influenzae Type B Vaccine Sales Share by Type (2015-2020)
Table 31. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2015-2020)
Table 33. Haemophilus Influenzae Type B Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 34. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2015-2020) (M Doses)
Table 35. Global Haemophilus Influenzae Type B Vaccine Sales Share by Application (2015-2020)
Table 36. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2015-2020) (M Doses)
Table 37. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2015-2020)
Table 38. North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2015-2020)
Table 40. North America Haemophilus Influenzae Type B Vaccine Sales by Type (2015-2020) (M Doses)
Table 41. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 42. North America Haemophilus Influenzae Type B Vaccine Sales by Application (2015-2020) (M Doses)
Table 43. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Table 44. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2015-2020) (M Doses)
Table 45. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2015-2020)
Table 46. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2015-2020)
Table 48. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2015-2020) (M Doses)
Table 49. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 50. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2015-2020) (M Doses)
Table 51. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2015-2020) (M Doses)
Table 53. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2015-2020) (M Doses)
Table 57. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2015-2020) (M Doses)
Table 59. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Table 60. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2015-2020) (M Doses)
Table 61. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Haemophilus Influenzae Type B Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2015-2020)
Table 64. Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2015-2020) (M Doses)
Table 65. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 66. Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2015-2020) (M Doses)
Table 67. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2015-2020) (M Doses)
Table 69. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2015-2020) (M Doses)
Table 73. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2015-2020) (M Doses)
Table 75. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Table 76. Novartis Corporation Information
Table 77. Novartis Description and Major Businesses
Table 78. Novartis Haemophilus Influenzae Type B Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 79. Novartis Product
Table 80. Novartis Recent Development
Table 81. Merck Corporation Information
Table 82. Merck Description and Major Businesses
Table 83. Merck Haemophilus Influenzae Type B Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 84. Merck Product
Table 85. Merck Recent Development
Table 86. Sanofi Corporation Information
Table 87. Sanofi Description and Major Businesses
Table 88. Sanofi Haemophilus Influenzae Type B Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 89. Sanofi Product
Table 90. Sanofi Recent Development
Table 91. GlaxoSmithKline Corporation Information
Table 92. GlaxoSmithKline Description and Major Businesses
Table 93. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 94. GlaxoSmithKline Product
Table 95. GlaxoSmithKline Recent Development
Table 96. Takeda Pharmaceuticals Company Corporation Information
Table 97. Takeda Pharmaceuticals Company Description and Major Businesses
Table 98. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 99. Takeda Pharmaceuticals Company Product
Table 100. Takeda Pharmaceuticals Company Recent Development
Table 101. Walvax Biotechnology Corporation Information
Table 102. Walvax Biotechnology Description and Major Businesses
Table 103. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 104. Walvax Biotechnology Product
Table 105. Walvax Biotechnology Recent Development
Table 106. Lanzhou Institute of Biologica Corporation Information
Table 107. Lanzhou Institute of Biologica Description and Major Businesses
Table 108. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 109. Lanzhou Institute of Biologica Product
Table 110. Lanzhou Institute of Biologica Recent Development
Table 111. Immunize BC Corporation Information
Table 112. Immunize BC Description and Major Businesses
Table 113. Immunize BC Haemophilus Influenzae Type B Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 114. Immunize BC Product
Table 115. Immunize BC Recent Development
Table 116. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Regions (2021-2026) (M Doses)
Table 117. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 118. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 119. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 120. North America: Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2021-2026) (M Doses)
Table 121. North America: Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Europe: Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2021-2026) (M Doses)
Table 123. Europe: Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Asia Pacific: Haemophilus Influenzae Type B Vaccine Sales Forecast by Region (2021-2026) (M Doses)
Table 125. Asia Pacific: Haemophilus Influenzae Type B Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 126. Latin America: Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2021-2026) (M Doses)
Table 127. Latin America: Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Middle East and Africa: Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2021-2026) (M Doses)
Table 129. Middle East and Africa: Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 131. Key Challenges
Table 132. Market Risks
Table 133. Main Points Interviewed from Key Haemophilus Influenzae Type B Vaccine Players
Table 134. Haemophilus Influenzae Type B Vaccine Customers List
Table 135. Haemophilus Influenzae Type B Vaccine Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 1. Haemophilus Influenzae Type B Vaccine Market Segments
Table 2. Ranking of Global Top Haemophilus Influenzae Type B Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Type 2020-2026 (M Doses) & (US$ Million)
Table 4. Major Manufacturers of Liquid Monovalent HIB
Table 5. Major Manufacturers of Liquid Combination HIB
Table 6. Major Manufacturers of Lyophilized Monovalent HIB
Table 7. Major Manufacturers of Lyophilized Combination HIB
Table 8. COVID-19 Impact Global Market: (Four Haemophilus Influenzae Type B Vaccine Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Haemophilus Influenzae Type B Vaccine Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Haemophilus Influenzae Type B Vaccine Players to Combat Covid-19 Impact
Table 13. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Application 2020-2026 (M Doses)
Table 14. Global Haemophilus Influenzae Type B Vaccine Market Size by Region (M Doses) & (US$ Million): 2020 VS 2026
Table 15. Global Haemophilus Influenzae Type B Vaccine Sales by Regions 2015-2020 (M Doses)
Table 16. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Regions (2015-2020)
Table 17. Global Haemophilus Influenzae Type B Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturers (2015-2020) (M Doses)
Table 19. Global Haemophilus Influenzae Type B Vaccine Sales Share by Manufacturers (2015-2020)
Table 20. Global Haemophilus Influenzae Type B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Haemophilus Influenzae Type B Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Haemophilus Influenzae Type B Vaccine as of 2019)
Table 22. Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Haemophilus Influenzae Type B Vaccine Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Haemophilus Influenzae Type B Vaccine Price (2015-2020) (USD/Dose)
Table 25. Haemophilus Influenzae Type B Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Haemophilus Influenzae Type B Vaccine Product Type
Table 27. Date of International Manufacturers Enter into Haemophilus Influenzae Type B Vaccine Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2015-2020) (M Doses)
Table 30. Global Haemophilus Influenzae Type B Vaccine Sales Share by Type (2015-2020)
Table 31. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2015-2020)
Table 33. Haemophilus Influenzae Type B Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 34. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2015-2020) (M Doses)
Table 35. Global Haemophilus Influenzae Type B Vaccine Sales Share by Application (2015-2020)
Table 36. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2015-2020) (M Doses)
Table 37. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2015-2020)
Table 38. North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2015-2020)
Table 40. North America Haemophilus Influenzae Type B Vaccine Sales by Type (2015-2020) (M Doses)
Table 41. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 42. North America Haemophilus Influenzae Type B Vaccine Sales by Application (2015-2020) (M Doses)
Table 43. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Table 44. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2015-2020) (M Doses)
Table 45. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2015-2020)
Table 46. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2015-2020)
Table 48. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2015-2020) (M Doses)
Table 49. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 50. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2015-2020) (M Doses)
Table 51. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2015-2020) (M Doses)
Table 53. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2015-2020) (M Doses)
Table 57. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2015-2020) (M Doses)
Table 59. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Table 60. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2015-2020) (M Doses)
Table 61. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Haemophilus Influenzae Type B Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2015-2020)
Table 64. Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2015-2020) (M Doses)
Table 65. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 66. Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2015-2020) (M Doses)
Table 67. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2015-2020) (M Doses)
Table 69. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2015-2020) (M Doses)
Table 73. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2015-2020) (M Doses)
Table 75. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Table 76. Novartis Corporation Information
Table 77. Novartis Description and Major Businesses
Table 78. Novartis Haemophilus Influenzae Type B Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 79. Novartis Product
Table 80. Novartis Recent Development
Table 81. Merck Corporation Information
Table 82. Merck Description and Major Businesses
Table 83. Merck Haemophilus Influenzae Type B Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 84. Merck Product
Table 85. Merck Recent Development
Table 86. Sanofi Corporation Information
Table 87. Sanofi Description and Major Businesses
Table 88. Sanofi Haemophilus Influenzae Type B Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 89. Sanofi Product
Table 90. Sanofi Recent Development
Table 91. GlaxoSmithKline Corporation Information
Table 92. GlaxoSmithKline Description and Major Businesses
Table 93. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 94. GlaxoSmithKline Product
Table 95. GlaxoSmithKline Recent Development
Table 96. Takeda Pharmaceuticals Company Corporation Information
Table 97. Takeda Pharmaceuticals Company Description and Major Businesses
Table 98. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 99. Takeda Pharmaceuticals Company Product
Table 100. Takeda Pharmaceuticals Company Recent Development
Table 101. Walvax Biotechnology Corporation Information
Table 102. Walvax Biotechnology Description and Major Businesses
Table 103. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 104. Walvax Biotechnology Product
Table 105. Walvax Biotechnology Recent Development
Table 106. Lanzhou Institute of Biologica Corporation Information
Table 107. Lanzhou Institute of Biologica Description and Major Businesses
Table 108. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 109. Lanzhou Institute of Biologica Product
Table 110. Lanzhou Institute of Biologica Recent Development
Table 111. Immunize BC Corporation Information
Table 112. Immunize BC Description and Major Businesses
Table 113. Immunize BC Haemophilus Influenzae Type B Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 114. Immunize BC Product
Table 115. Immunize BC Recent Development
Table 116. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Regions (2021-2026) (M Doses)
Table 117. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 118. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 119. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 120. North America: Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2021-2026) (M Doses)
Table 121. North America: Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Europe: Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2021-2026) (M Doses)
Table 123. Europe: Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Asia Pacific: Haemophilus Influenzae Type B Vaccine Sales Forecast by Region (2021-2026) (M Doses)
Table 125. Asia Pacific: Haemophilus Influenzae Type B Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 126. Latin America: Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2021-2026) (M Doses)
Table 127. Latin America: Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Middle East and Africa: Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2021-2026) (M Doses)
Table 129. Middle East and Africa: Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 131. Key Challenges
Table 132. Market Risks
Table 133. Main Points Interviewed from Key Haemophilus Influenzae Type B Vaccine Players
Table 134. Haemophilus Influenzae Type B Vaccine Customers List
Table 135. Haemophilus Influenzae Type B Vaccine Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Haemophilus Influenzae Type B Vaccine Product Picture
Figure 2. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Liquid Monovalent HIB Product Picture
Figure 4. Liquid Combination HIB Product Picture
Figure 5. Lyophilized Monovalent HIB Product Picture
Figure 6. Lyophilized Combination HIB Product Picture
Figure 7. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Research Institutions
Figure 10. Pharmaceutical and Biotechnology Companies
Figure 11. Academic Institutions
Figure 12. Other
Figure 13. Haemophilus Influenzae Type B Vaccine Report Years Considered
Figure 14. Global Haemophilus Influenzae Type B Vaccine Market Size 2015-2026 (US$ Million)
Figure 15. Global Haemophilus Influenzae Type B Vaccine Sales 2015-2026 (M Doses)
Figure 16. Global Haemophilus Influenzae Type B Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2015-2020)
Figure 18. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region in 2019
Figure 19. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2015-2020)
Figure 20. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region in 2019
Figure 21. Global Haemophilus Influenzae Type B Vaccine Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Haemophilus Influenzae Type B Vaccine Revenue in 2019
Figure 23. Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Figure 25. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2019
Figure 26. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2015-2020)
Figure 27. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type in 2019
Figure 28. Global Haemophilus Influenzae Type B Vaccine Market Share by Price Range (2015-2020)
Figure 29. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Figure 30. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application in 2019
Figure 31. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2015-2020)
Figure 32. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application in 2019
Figure 33. North America Haemophilus Influenzae Type B Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 34. North America Haemophilus Influenzae Type B Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2019
Figure 36. North America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country in 2019
Figure 37. U.S. Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 38. U.S. Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 40. Canada Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Haemophilus Influenzae Type B Vaccine Market Share by Type in 2019
Figure 42. North America Haemophilus Influenzae Type B Vaccine Market Share by Application in 2019
Figure 43. Europe Haemophilus Influenzae Type B Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 44. Europe Haemophilus Influenzae Type B Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2019
Figure 46. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country in 2019
Figure 47. Germany Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 48. Germany Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 50. France Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 52. U.K. Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 54. Italy Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 56. Russia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Haemophilus Influenzae Type B Vaccine Market Share by Type in 2019
Figure 58. Europe Haemophilus Influenzae Type B Vaccine Market Share by Application in 2019
Figure 59. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 60. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Region in 2019
Figure 62. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region in 2019
Figure 63. China Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 64. China Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 66. Japan Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 68. South Korea Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 70. India Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 72. Australia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 74. Taiwan Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 76. Indonesia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 78. Thailand Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 80. Malaysia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 82. Philippines Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 84. Vietnam Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Haemophilus Influenzae Type B Vaccine Market Share by Type in 2019
Figure 86. Asia Pacific Haemophilus Influenzae Type B Vaccine Market Share by Application in 2019
Figure 87. Latin America Haemophilus Influenzae Type B Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 88. Latin America Haemophilus Influenzae Type B Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2019
Figure 90. Latin America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country in 2019
Figure 91. Mexico Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 92. Mexico Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 94. Brazil Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 96. Argentina Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Haemophilus Influenzae Type B Vaccine Market Share by Type in 2019
Figure 98. Latin America Haemophilus Influenzae Type B Vaccine Market Share by Application in 2019
Figure 99. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 100. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country in 2019
Figure 103. Turkey Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 104. Turkey Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 106. Saudi Arabia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 108. U.A.E Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Share by Type in 2019
Figure 110. Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Share by Application in 2019
Figure 111. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Takeda Pharmaceuticals Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Walvax Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Lanzhou Institute of Biologica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Immunize BC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Haemophilus Influenzae Type B Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 120. North America Haemophilus Influenzae Type B Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Haemophilus Influenzae Type B Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 122. Europe Haemophilus Influenzae Type B Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 124. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Haemophilus Influenzae Type B Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 126. Latin America Haemophilus Influenzae Type B Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 128. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
Figure 1. Haemophilus Influenzae Type B Vaccine Product Picture
Figure 2. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Liquid Monovalent HIB Product Picture
Figure 4. Liquid Combination HIB Product Picture
Figure 5. Lyophilized Monovalent HIB Product Picture
Figure 6. Lyophilized Combination HIB Product Picture
Figure 7. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Research Institutions
Figure 10. Pharmaceutical and Biotechnology Companies
Figure 11. Academic Institutions
Figure 12. Other
Figure 13. Haemophilus Influenzae Type B Vaccine Report Years Considered
Figure 14. Global Haemophilus Influenzae Type B Vaccine Market Size 2015-2026 (US$ Million)
Figure 15. Global Haemophilus Influenzae Type B Vaccine Sales 2015-2026 (M Doses)
Figure 16. Global Haemophilus Influenzae Type B Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2015-2020)
Figure 18. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region in 2019
Figure 19. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2015-2020)
Figure 20. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region in 2019
Figure 21. Global Haemophilus Influenzae Type B Vaccine Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Haemophilus Influenzae Type B Vaccine Revenue in 2019
Figure 23. Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2015-2020)
Figure 25. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2019
Figure 26. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2015-2020)
Figure 27. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type in 2019
Figure 28. Global Haemophilus Influenzae Type B Vaccine Market Share by Price Range (2015-2020)
Figure 29. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2015-2020)
Figure 30. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application in 2019
Figure 31. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2015-2020)
Figure 32. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application in 2019
Figure 33. North America Haemophilus Influenzae Type B Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 34. North America Haemophilus Influenzae Type B Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2019
Figure 36. North America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country in 2019
Figure 37. U.S. Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 38. U.S. Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 40. Canada Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Haemophilus Influenzae Type B Vaccine Market Share by Type in 2019
Figure 42. North America Haemophilus Influenzae Type B Vaccine Market Share by Application in 2019
Figure 43. Europe Haemophilus Influenzae Type B Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 44. Europe Haemophilus Influenzae Type B Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2019
Figure 46. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country in 2019
Figure 47. Germany Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 48. Germany Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 50. France Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 52. U.K. Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 54. Italy Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 56. Russia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Haemophilus Influenzae Type B Vaccine Market Share by Type in 2019
Figure 58. Europe Haemophilus Influenzae Type B Vaccine Market Share by Application in 2019
Figure 59. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 60. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Region in 2019
Figure 62. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region in 2019
Figure 63. China Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 64. China Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 66. Japan Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 68. South Korea Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 70. India Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 72. Australia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 74. Taiwan Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 76. Indonesia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 78. Thailand Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 80. Malaysia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 82. Philippines Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 84. Vietnam Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Haemophilus Influenzae Type B Vaccine Market Share by Type in 2019
Figure 86. Asia Pacific Haemophilus Influenzae Type B Vaccine Market Share by Application in 2019
Figure 87. Latin America Haemophilus Influenzae Type B Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 88. Latin America Haemophilus Influenzae Type B Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2019
Figure 90. Latin America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country in 2019
Figure 91. Mexico Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 92. Mexico Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 94. Brazil Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 96. Argentina Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Haemophilus Influenzae Type B Vaccine Market Share by Type in 2019
Figure 98. Latin America Haemophilus Influenzae Type B Vaccine Market Share by Application in 2019
Figure 99. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 100. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country in 2019
Figure 103. Turkey Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 104. Turkey Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 106. Saudi Arabia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Haemophilus Influenzae Type B Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 108. U.A.E Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Share by Type in 2019
Figure 110. Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Share by Application in 2019
Figure 111. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Takeda Pharmaceuticals Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Walvax Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Lanzhou Institute of Biologica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Immunize BC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Haemophilus Influenzae Type B Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 120. North America Haemophilus Influenzae Type B Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Haemophilus Influenzae Type B Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 122. Europe Haemophilus Influenzae Type B Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 124. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Haemophilus Influenzae Type B Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 126. Latin America Haemophilus Influenzae Type B Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 128. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
